Ara-290
18032976590@mammoth-biotech.com
Product Description
Basic Info.
ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes.ARA 290 has been shown to be effective in the reduction of inflammation and activation of the healing process in a wide variety of preclinical models as well as in patients.
With respect to diabetes, substantial recent work has shown that rhEPO can improve the diabetic state in animal models . However, in addition to interacting with the innate repair receptor in a paracrine/autocrine manner, EPO also functions as a circulating hormone via its interaction with the EPO receptor homodimer that mediates hematopoiesis.
“Strength builds the foundation, and excellent services reach all over the world.”
create win-win situation with customers
We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.
Related Products
Gonadorelin Acetate
Basic Info. Gonadorelin acetate is a synthetic decapeptide that serves as gonadotropin-releasing hormone.analogue.It is used therapeutically under several trade names ,including lutrepules and factrel.The primary targets for gonadotrope ce ...
Triptorelin Acetate/GnRH Triptorelin Selank
Basic Info. Triptorelin is a synthetic decapeptide hormone which falls under the gonadotropin-release hormone agoist untilized as the pamoates or acetate salts. (GnRH) utilized as the pamoates or acetat ...
Tirzepatide
Basic Info. Tirzepatide is a revolutionary medication used primarily for managing weight and blood sugar levels. It works by mimicking two naturally oc ...
Oxytocin Acetate
Basic Info. Oxytocin acetate is a form of the hormone oxytocin, a nonapeptide known for its role in uterine contractions, lactation, and various social behaviors. It's synthesized in the hypothalamus and released i ...
Semaglutide
Basic Info. Semaglutide is a GLP-1 receptor agonist (incretin mimetic) used to treat type 2 diabetes and obesity . It stimulates insulin release , suppresses glucagon secretion , slows ...